|1.||Chen, Bing-Huei: 1 article (07/2010)|
|2.||Su, Yi-Ting: 1 article (07/2010)|
|3.||Lin, Yuh-Ling: 1 article (07/2010)|
|4.||Begleiter, A: 1 article (11/2000)|
05/06/1967 - "[Serum enzyme studies during intra-arterial Trenimon therapy of genital carcinoma]."
09/01/1965 - "Studies on the local administration of 2,3,5-tri-ethylene-imino-1,4-benzoquinone (Trenimon) to epitheliomas."
02/01/1986 - "Two hundred forty-eight women from 1969-71 who underwent surgery for carcinoma of the cervix and were treated with triaziquone (0.2 mg i.v. daily) from day 2-5 after the operation, are compared to a group of 301 conventionally treated patients examined over the 3 following years. "
01/01/1972 - "Results of treatment of Guerin transplantable epithelioma with trenimon and Roentgen irradiation."
06/04/1971 - "[Successful, local application of trenimon in the therapy of genital carcinomas and their relapses]."
10/01/1964 - "[EXPERIMENTAL STUDIES ON THE EFFECT OF CO60 GAMMA-RAYS AND TRENIMON (TRISETHYLENEIMINOBENZOQUINONE)-ALONE AND IN COMBINATION - ON THE NUCLEUS AND NUCLEOLUS OF CANCER CELLS (HELA STRAIN) IN THE INTERPHASE IN VITRO]."
01/01/1971 - "[Effect of trenimon (2.3.5.-triethyleneiminebenzoquinone) and X-rays on therapeutical results in experimental tumors]."
12/01/1966 - "[Research on the anti-cancer effects of a recently synthesized-alkylating agent, trenimon]."
10/15/1966 - "[The action of trenimon on energy metabolism and growth of tumor cells]."
06/01/1965 - "[Apropos of the use of trenimon in the treatment of cancer of the reproductive organs]."
|3.||Chromosome Aberrations (Chromosome Abnormalities)
01/01/1979 - "[Chromosome aberrations in oncobiogram - cytogenetic studies into aberration frequency following trenimon treatment in vitro (author's transl)]."
10/01/1978 - "The comparative triaziquone study has provided arguments in favor of the micronucleus test as a reliable screening method for chromosomal aberrations. "
05/01/1985 - "Influence of Neurospora endonuclease on trenimon-induced structural chromosomal aberrations and sister-chromatid exchanges in human peripheral lymphocytes and Chinese hamster ovary cells."
08/01/1984 - "Liquid holding of trenimon-treated human peripheral lymphocytes in the G0 stage of the cell cycle leads to an elevation in the frequencies of chromosome aberrations and a decrease in the frequencies of chromatid aberrations. "
11/01/1980 - "These results, which are discussed, indicate that T cells (early dividing) are more sensitive with respect to the induction of SCEs and structural chromosomal aberrations by Trenimon as compared with B cells (late dividing)."
01/01/1986 - "Trenimon at highly toxic concentrations had no effect on the fluidity of phospholipid membranes or of membranes of Ehrlich ascites tumour cells as analysed by ESR spin-label methods. "
08/24/1962 - "[Biochemical studies on ascites tumor cells under the influence of Trenimon]."
03/28/1966 - "[Stimulation of DPN metabolic processes in ascites tumors by low dosage roentgen irradiation and trenimon]."
12/01/1996 - "Cytogenetic studies confirmed the clinical diagnosis and revealed a spontaneous chromosomal instability and hypersensitivity to the cross-linking agents diepoxybutane and Trenimon. "
10/01/1993 - "A high frequency of spontaneous chromosomal breakage, endomitosis, endoreduplication and hypersensitivity toward both the alkylating agent Trenimon and the radiomimetric drug bleomycin was observed in phytohemagglutinin-stimulated peripheral lymphocytes from a girl with craniosynostosis, microcephaly, ptosis, bird-like facies, and moderate mental retardation. "
|2.||erythritol anhydride (butanedione)
|4.||DNA (Deoxyribonucleic Acid)
|9.||Mechlorethamine (Nitrogen Mustard)
|2.||Drug Therapy (Chemotherapy)